AfroCentric, a leading investment holding company in South Africa’s healthcare sector, has reported mixed financial results for the year ending June 2024. Despite significant impairments that impacted overall profitability, the company saw an improvement in headline earnings, signalling a gradual recovery in the South African pharmaceutical sector to pre-pandemic levels. In 2023, Sanlam acquired a controlling stake in AfroCentric, which…